14.21
-0.15
(-1.04%)
At close: 4:00:02 PM EST
13.96
-0.25
(-1.76%)
After hours: 4:54:51 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
ECOR1 CAPITAL, L.L.C. Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 2, 2025 | -- |
FAGA DANIEL R Chief Executive Officer | Conversion of Exercise of derivative security | Jan 6, 2025 | 436,466 |
FENTON DENNIS M Director | Sale | Jun 21, 2024 | 1,950 |
JAIN RITA Director | Conversion of Exercise of derivative security | Jun 14, 2024 | 4,534 |
LIZZUL PAUL F. Officer | Conversion of Exercise of derivative security | Jan 6, 2025 | 25,643 |
LOUMEAU ERIC JOSEPH Officer | Conversion of Exercise of derivative security | Jan 6, 2025 | 11,003 |
MULROY DENNIS MICHAEL CPA Chief Financial Officer | Conversion of Exercise of derivative security | Jan 6, 2025 | 13,802 |
ORWIN JOHN A Director | Conversion of Exercise of derivative security | Sep 13, 2024 | 3,335 |
RENTON HOLLINGS C Director | Conversion of Exercise of derivative security | Nov 29, 2024 | 1,950 |
SCHMID JOHN P Director | Conversion of Exercise of derivative security | Jun 14, 2024 | 3,900 |
Related Tickers
ZYME Zymeworks Inc.
13.22
-6.44%
EWTX Edgewise Therapeutics, Inc.
24.15
-5.00%
VTYX Ventyx Biosciences, Inc.
2.0800
-7.56%
NUVL Nuvalent, Inc.
76.61
-2.10%
TYRA Tyra Biosciences, Inc.
15.20
-4.82%
AGIO Agios Pharmaceuticals, Inc.
34.42
-4.12%
SYRE Spyre Therapeutics, Inc.
22.46
-6.49%
PRTA Prothena Corporation plc
13.05
-7.84%
MLYS Mineralys Therapeutics, Inc.
9.87
-11.87%
OLMA Olema Pharmaceuticals, Inc.
5.04
-12.35%